FDA panel backs much-debated ALS drug in rare, 2nd review

📆 9/8/2022 11:45 AM
📰 medical_xpress

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year.

retrieved 8 September 2022 from https://medicalxpress.com/news/2022-09-fda-panel-much-debated-als-drug.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines